Description
Aurorix Lak is an antidepressant that selectively and reversibly inhibits MAO type A, inhibits the metabolism of serotonin (mainly), norepinephrine and dopamine, and increases their content in the central nervous system. Possessing an antidepressant effect, it improves mood and concentration, eliminates fatigue, dysphoria, nervous exhaustion, psychomotor retardation, and improves sleep.
It contains the drug moclobemide, an antidepressant that helps improve mood and return to normal survival. It is used to treat depression and social phobia.
The optimal antidepressant effect develops when MAO is inhibited by 60-80%. The action is manifested by the end of the first week of treatment. Does not adversely affect the reaction rate.
Pharmacological properties: indications: Is indicated for the treatment of depressive syndromes and social phobia. contraindications:
* Moklobemide or for use in patients with known hypersensitivity to any component of the drug
Warnings / Precautions:
As with other antidepressants in depressed patients with schizophrenia or schizoaffective psychosis is used, the increase in schizophrenic symptoms Can be seen. In such patients, if possible, treatment should be continued long-acting neuroleptics. In general, special dietary restrictions are not necessary during therapy with moclobemide. Tiramine hypersensitivity may occur in some patients, all patients should be eaten when excessive amounts of foods containing high amounts of tyramine. As it is known antidepressant therapy, patients with suicidal tendencies should be monitored carefully.
Hypersensitivity reactions may occur in susceptible individuals. Rash and edema. Theoretical pharmacological approach, MAO inhibitors may cause a hypertensive reaction in patients with pheochromocytoma, thyrotoxicosis and shape. As experience with the use of moclobemide in this population group, caution should be exercised when deciding on the use of moclobemide. Aurorix the patients, as well as other drugs that enhance serotonin, especially in case of repeated use of combinations of drugs must be careful. This is especially true for clomipramine (see Drug Interactions).
There are no reviews yet.